JP Morgan: maintains an "overweight" rating on JD-SW (09618) with a target price of 200 Hong Kong dollars.
The report said that JD's performance in the last quarter was stable and better than expected, and it is expected that the stock price will have a positive response.
JPMorgan Chase released a research report stating that it maintains a "buy" rating for JD-SW (09618) with a target price of 200 Hong Kong dollars. JD's revenue in the last quarter increased by 13% year-on-year, higher than the bank's and market forecasts; adjusted net profit increased by 34% year-on-year, and adjusted earnings per share increased by 40%, both higher than the bank's and market forecasts. The bank stated that JD's performance in the last quarter was solid and exceeded expectations, and expects the stock price to have a positive response. During the period, the group's revenue increased by 13% year-on-year, higher than the bank's and market forecasts by 10% and 9% respectively; adjusted net profit increased by 34% year-on-year; adjusted earnings per share increased by 40%, which is 18% and 20% higher than the bank's and market forecasts, respectively.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






